<bill session="116" type="h" number="6925" updated="2023-01-11T13:42:52Z">
  <state datetime="2020-05-19">REFERRED</state>
  <status>
    <introduced datetime="2020-05-19"/>
  </status>
  <introduced datetime="2020-05-19"/>
  <titles>
    <title type="display">Medical Innovation Acceleration Act of 2020</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.</title>
    <title type="short" as="introduced">Medical Innovation Acceleration Act of 2020</title>
  </titles>
  <sponsor bioguide_id="B001302"/>
  <cosponsors/>
  <actions>
    <action datetime="2020-05-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-05-19" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative remedies"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Food and Drug Administration (FDA)"/>
  </subjects>
  <amendments/>
  <summary date="2020-12-29T15:21:08Z" status="Introduced in House">Medical Innovation Acceleration Act of 2020

This bill exempts non-invasive diagnostic devices from the regulatory authority of the Food and Drug Administration.

The bill defines non-invasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.</summary>
</bill>
